267 related articles for article (PubMed ID: 17548576)
1. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura.
Stasi R; Del Poeta G; Stipa E; Evangelista ML; Trawinska MM; Cooper N; Amadori S
Blood; 2007 Oct; 110(8):2924-30. PubMed ID: 17548576
[TBL] [Abstract][Full Text] [Related]
2. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
Chang-Lin WU; Jian-Cheng XU; Fang LI; Hong XI; Xue-Min ZH; Qun CH; Xue-Wen LV
Int J Lab Hematol; 2007 Jun; 29(3):177-84. PubMed ID: 17474894
[TBL] [Abstract][Full Text] [Related]
3. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
Liu F; Wu C; Yang X; Xiao H; Zhuo X; Cheng Z; Chen Q
Cell Mol Immunol; 2005 Oct; 2(5):387-92. PubMed ID: 16368066
[TBL] [Abstract][Full Text] [Related]
4. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.
Stasi R; Cooper N; Del Poeta G; Stipa E; Laura Evangelista M; Abruzzese E; Amadori S
Blood; 2008 Aug; 112(4):1147-50. PubMed ID: 18375792
[TBL] [Abstract][Full Text] [Related]
5. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of peripheral blood T cell subsets in children with idiopathic thrombocytopenic purpura].
Xiao H; Liu F; Wu CL; Yang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):722-5. PubMed ID: 16928308
[TBL] [Abstract][Full Text] [Related]
7. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
Li J; Wang Z; Hu S; Zhao X; Cao L
Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
[TBL] [Abstract][Full Text] [Related]
8. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
[TBL] [Abstract][Full Text] [Related]
9. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.
Audia S; Samson M; Mahévas M; Ferrand C; Trad M; Ciudad M; Gautheron A; Seaphanh F; Leguy V; Berthier S; Salles B; Martin L; Lorcerie B; Ortega-Deballon P; Facy O; Caillot D; Soudry-Faure A; Michel M; Godeau B; Larmonier N; Saas P; Janikashvili N; Bonnotte B
Blood; 2013 Oct; 122(14):2477-86. PubMed ID: 23963041
[TBL] [Abstract][Full Text] [Related]
10. [Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura].
Wang TT; Zhao H; Ren H; Guo JH; Xu MQ; Yang RC; Han ZC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):669-73. PubMed ID: 16681922
[TBL] [Abstract][Full Text] [Related]
11. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.
Audia S; Rossato M; Trad M; Samson M; Santegoets K; Gautheron A; Bekker C; Facy O; Cheynel N; Ortega-Deballon P; Boulin M; Berthier S; Leguy-Seguin V; Martin L; Ciudad M; Janikashvili N; Saas P; Radstake T; Bonnotte B
J Autoimmun; 2017 Feb; 77():89-95. PubMed ID: 27863820
[TBL] [Abstract][Full Text] [Related]
12. Cytokine Profile, Apoptosis, Glucocorticoid Receptor, and P-glycoprotein Expression Before and After Megadose Methylprednisolone Treatment in Children With Acute Immune Thrombocytopenia.
Yalinbaş EE; Sezgin Evim M; Bör Ö; Gülbaş Z
J Pediatr Hematol Oncol; 2019 Oct; 41(7):574-578. PubMed ID: 30499912
[TBL] [Abstract][Full Text] [Related]
13. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.
Audia S; Samson M; Guy J; Janikashvili N; Fraszczak J; Trad M; Ciudad M; Leguy V; Berthier S; Petrella T; Aho-Glélé S; Martin L; Maynadié M; Lorcerie B; Rat P; Cheynel N; Katsanis E; Larmonier N; Bonnotte B
Blood; 2011 Oct; 118(16):4394-400. PubMed ID: 21876120
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
Torii Y; Yagasaki H; Tanaka H; Mizuno S; Nishio N; Muramatsu H; Hama A; Takahashi Y; Kojima S
Int J Hematol; 2009 Sep; 90(2):174-176. PubMed ID: 19662467
[TBL] [Abstract][Full Text] [Related]
16. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
Feng Q; Xu M; Yu YY; Hou Y; Mi X; Sun YX; Ma S; Zuo XY; Shao LL; Hou M; Zhang XH; Peng J
J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
[TBL] [Abstract][Full Text] [Related]
17. Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency.
Al-Ahmad M; Al-Rasheed M; Al-Muhani A
J Investig Allergol Clin Immunol; 2010; 20(3):259-62. PubMed ID: 20635793
[TBL] [Abstract][Full Text] [Related]
18. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
Kneitz C; Wilhelm M; Tony HP
Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
[TBL] [Abstract][Full Text] [Related]
19. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.
Wang T; Zhao H; Ren H; Guo J; Xu M; Yang R; Han ZC
Haematologica; 2005 Jul; 90(7):914-23. PubMed ID: 15996929
[TBL] [Abstract][Full Text] [Related]
20. Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.
Xie J; Cui D; Liu Y; Jin J; Tong H; Wang L; Ruan G; Lu Y; Yuan H
Int J Biol Sci; 2015; 11(2):220-9. PubMed ID: 25561904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
